ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $912.18 million. The enterprise value is $629.54 million.

Market Cap	912.18M
Enterprise Value	629.54M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 33.70 million shares outstanding. The number of shares has increased by 1,230.98% in one year.

Current Share Class	33.70M
Shares Outstanding	33.70M
Shares Change (YoY)	+1,230.98%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	2.65%
Owned by Institutions (%)	49.64%
Float	15.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.29
P/TBV Ratio	3.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.28, with a Debt / Equity ratio of 0.00.

Current Ratio	19.28
Quick Ratio	18.69
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.07% and return on invested capital (ROIC) is -26.05%.

Return on Equity (ROE)	-36.07%
Return on Assets (ROA)	-24.68%
Return on Invested Capital (ROIC)	-26.05%
Return on Capital Employed (ROCE)	-33.77%
Revenue Per Employee	n/a
Profits Per Employee	-$2.03M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.22%
50-Day Moving Average	26.86
200-Day Moving Average	24.54
Relative Strength Index (RSI)	49.67
Average Volume (20 Days)	152,025

Short Selling Information

The latest short interest is 4.32 million, so 12.81% of the outstanding shares have been sold short.

Short Interest	4.32M
Short Previous Month	3.96M
Short % of Shares Out	12.81%
Short % of Float	27.71%
Short Ratio (days to cover)	31.00

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.72M
Pretax Income	n/a
Net Income	-81.05M
EBITDA	n/a
EBIT	-93.72M
Earnings Per Share (EPS)	-$3.42

Full Income Statement

Balance Sheet

The company has $282.86 million in cash and $213,000 in debt, giving a net cash position of $282.64 million or $8.39 per share.

Cash & Cash Equivalents	282.86M
Total Debt	213,000
Net Cash	282.64M
Net Cash Per Share	$8.39
Equity (Book Value)	277.49M
Book Value Per Share	8.24
Working Capital	277.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-68.97M
Capital Expenditures	n/a
Free Cash Flow	-68.97M
FCF Per Share	-$2.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,230.98%
Shareholder Yield	-1,230.98%
Earnings Yield	-8.89%
FCF Yield	-7.56%

Analyst Forecast

The average price target for AVBP is $38.00, which is 40.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.00
Price Target Difference	40.38%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2